Evidence map›Paper›PMID 42094040›Full record

ArticleResearch square2026

Glial multicellular programs reveal distinct patient stratification in Parkinson's disease.

Juan Manuel Barba-Reyes, Sergio Marco Salas, Gabriel Gonzalez-Ulloa, Lisbeth Harder, Nima Rafati, Maria Chatzinikolaou, Fabian J Theis, Bradley T Hyman, Alberto Serrano-Pozo, Mats Nilsson and 1 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Juan Manuel Barba-ReyesUnit of Cell Biology, Department of Neuroscience, Institute for Biomedical Research and Innovation of Cádiz (INiBICA), University of Cádiz, Cádiz, Spain.
Sergio Marco SalasInstitute of Computational Biology, Helmholtz Center, Munich, Germany.
Gabriel Gonzalez-UlloaUnit of Cell Biology, Department of Neuroscience, Institute for Biomedical Research and Innovation of Cádiz (INiBICA), University of Cádiz, Cádiz, Spain.
Lisbeth HarderLaboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Nima RafatiNational Bioinformatics Infrastructure Sweden, Uppsala University, SciLifeLab, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.
Maria ChatzinikolaouScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Fabian J TheisInstitute of Computational Biology, Helmholtz Center, Munich, Germany.
Bradley T HymanDepartment of Neurology, Massachusetts General Hospital, Boston Massachusetts, USA.ORCID 0000-0002-7959-9401
Alberto Serrano-PozoDepartment of Neurology, Massachusetts General Hospital, Boston Massachusetts, USA.ORCID 0000-0003-0899-7530
Mats NilssonScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.ORCID 0000-0001-9985-0387
Ana B Muñoz-ManchadoUnit of Cell Biology, Department of Neuroscience, Institute for Biomedical Research and Innovation of Cádiz (INiBICA), University of Cádiz, Cádiz, Spain.ORCID 0000-0002-1121-6072

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Sudeshna Das · 2019 to 2026
$36.5M
The Role of Reactive Astrocytes in the Propagation and Clearance of Tau in Alzheimer's DiseaseR01AG089349 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Alberto Serrano-Pozo · 2025 to 2026
$975k
Reactive Astrogliosis and the Tripartite Synapse in Alzheimer's DiseaseR21AG087072 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SERRANO-POZO, ALBERTO · 2025 to 2025
$453k
NIA NIH HHS P30 AG062421NIA NIH HHS R01 AG089349NIA NIH HHS R21 AG087072
6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by nigrostriatal degeneration. While the role of glial cells in PD is increasingly recognized, the coordinated multicellular responses driving PD within the dorsal striatum remain poorly understood. By integrating single-nucleus RNA sequencing of 56 donors with targeted spatial transcriptomics, we disentangle regional from PD-related molecular programs across astrocytes, microglia and oligodendroglia. We identify PD-associated glial subpopulations organized into two distinct multicellular programs: one inflammatory and one UPR-associated, where each patient is dominated by one of these programs. Notably, these programs partition the molecular changes typically associated with PD into two specific, non-overlapping signatures. Multi-region analysis revealed these signatures are globally enriched across the sampled areas and Lewy body disease stages, from brainstem-predominant to neocortical, demonstrating that PD is characterized by mutually exclusive, brain-wide glial multicellular states. Our findings redefine glial alterations in PD as systemic and multicellular, providing a framework for patient stratification and the development of targeted, state-specific therapeutic interventions.

Identifiers

PMID42094040
PMCPMC13142618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.